CCaTS: Accelerating discoveries toward better health
Mayo Clinic Center for Clinical and Translational Science (CCaTS) is a central hub for institutional advancement of research and education at Mayo Clinic. The center provides tools and expert consultation to support every aspect of medical research, including basic discovery science, clinical and community-engaged research, and late-stage application and commercialization.
CCaTS is led by Claudia Lucchinetti, M.D., principal investigator and director of CCaTS and dean for clinical and translational science at Mayo Clinic. David O. Warner, M.D., is co-principal investigator and associate director of CCaTS, and is also principal investigator of the KL2 mentored career development grant. Anthony J. Windebank, M.D., is principal investigator of the TL1 predoctoral training grant.
News
Exploring health care disparities in minority populations
In recognition of National Minority Health Month, a number of Mayo Clinic experts participated in a virtual Mayo Clinic media briefing to discuss health care disparities that affect racial and ethnic minority populations in the U.S.
Read more on the Mayo Clinic News Network.
Study finds virtual community platform beneficial for engagement in health research
Community engagement is the bridge that connects researchers and local communities; however, face-to-face engagement is often limited in reach and scale — especially during a pandemic. In a recently published paper, researchers from Mayo Clinic and the University of Minnesota evaluated the feasibility of a virtual statewide Facebook community platform to enhance public trust and engagement with health research in Minnesota.
Read more on Mayo's Advancing the Science blog.
Balancing damage and protection, neutrophils may lead to cell aging
The action of an immune cell called a neutrophil may contribute to tissue aging, according to a new study. As neutrophils do their job, they may damage chromosomes in nearby cells which, over time, may lead to cellular senescence. This new concept may help clarify cell aging. It also suggests targeting neutrophils might be helpful in treatment of age-related disease.
Read more on Mayo's Discovery's Edge blog.
The COVID-19 Gap: Addressing the pandemic racial divide
In this feature of the COVID-19 Gap: Addressing the Pandemic Racial Divide, R-Town discusses the large divide in COVID-19 hospitalizations and deaths between the white and black communities in Minnesota. Joining her in this discussion is Dr. LaPrincess Brewer, M.D., a cardiologist with a primary focus in developing strategies to reduce cardiovascular disease health disparities in racial and ethnic minority populations, and Pastor Kenneth Rowe.
Watch the story on YouTube.
Mayo study examines how Latino participants experience genomic medicine
How do people from minority communities experience genomic medicine in diverse health-care settings? How do they integrate genetic knowledge into their understandings of health-care needs? These answers are critical to researchers as multiple efforts are underway to increase the inclusion of racial minority participants in genomic research and new forms of individualized medicine.
Read more on Mayo's Individualized Medicine blog.